← FDA Drug Approvals (Drugs@FDA)

EMBEDA

NDA · New Drug Application · Sponsor: ALPHARMA PHARMS · Approved 2009-08-13

Drug application

FDA Application #
NDA022321
Application type
New Drug Application
Brand name
EMBEDA
Generic name
Morphine Sulfate
Active ingredients
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing status
Discontinued
Sponsor
ALPHARMA PHARMS
First approval
2009-08-13

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown